• Skip to main content

The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.

We use cookies

Necessary cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytics cookies

Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.

ON OFF

Clarity

Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.

ON OFF

Privacy policy


  • Research
  • Viruses We Study A-Z
  • Hepatitis C virus
  • Study
  • Research
  • Explore
  • Connect
Search icon
Close menu icon
Menu icon bar 1 Menu icon bar 2 Menu icon bar 3
University of Glasgow logo small University of Glasgow logo
  • Home
  • Research
  • Research units A-Z
  • MRC-University of Glasgow Centre for Virus Research
  • Research
  • Viruses We Study A-Z
  • Hepatitis C virus

MRC-University of Glasgow Centre for Virus Research

  • Research
  • Viruses We Study A-Z
  • Hepatitis C virus

Hepatitis C virus

Hepatitis C virus (HCV) infects an estimated 2.2% of the world population, which equates to about 130 million people. The virus usually establishes a chronic infection in the liver that promotes serious hepatic disorders such as decompensated cirrhosis and hepatocellular carcinoma over a period that can take decades. Chronic HCV infection is a global healthcare problem due to uncoordinated intervention strategies to halt the spread of infection, lack of diagnosis and poor access to therapy. The virus has a positive-sense RNA genome, which is a highly variable in nucleotide sequence. As a consequence, developing anti-viral compounds that cure infection has been challenging and no vaccine is available.

CVR researchers are investigating the genetic diversity of HCV at the human population level; the immune response & host factors that control infection; design and development of a HCV B-cell vaccine.

Contact: John Mclauchlan, Arvind Patel, Emma Thomson

[Top]

HCV variation

Variation of HCV genotype 1a sequences in Scotland and other countries.

Viral hepatitis programme

Return to Viruses We Study

Back to the top

STUDY

  • Subjects A-Z
  • Undergraduate
  • Postgraduate
  • Online study
  • Short courses
  • International students
  • Student life
  • Scholarships and funding
  • Visit us / Open Days

RESEARCH

  • Research units A-Z
  • Research opportunities A-Z
  • Glasgow Research Beacons
  • Research strategy & policies
  • Research excellence
  • Our research environment

EXPLORE

  • Meet World Changing Glasgow
  • City of Glasgow
  • Visit us
  • Accessibility
  • Maps and travel
  • News 
  • Events
  • Schools
  • Colleges
  • Services
  • Library
  • University strategies

CONNECT

  • Staff A-Z
  • Information for our alumni
  • Support us
  • Business & innovation
  • Community and public engagement
  • Social Media listings
  • Ask a student
  • Complaints

JOBS AT GLASGOW

  • Current vacancies

University of Glasgow

  • Facebook
  • Bluesky
  • Instagram
  • YouTube
  • Twitter
  • tiktok
  • Linkedin
  • bilibili
  • Little Red Book
  • WeChat
  • Weibo

The University of Glasgow is a registered Scottish charity: Registration Number SC004401

MRC-University of Glasgow Centre for Virus Research

  • Contact us

Legal

  • Accessibility statement
  • Freedom of information
  • FOI publication scheme
  • Modern Slavery Statement
  • Privacy and cookies
  • Terms of use

Current students

  • MyGlasgow Students

Staff

  • MyGlasgow Staff
together against gender-based violence